SIRAKOSS was granted two U.S. patents covering synthetic bone graft technologies, and seeks to raise £3.5MM to £5.0MM in support of U.S. and EU regulatory approvals.
DePuy Synthes received FDA 510(k) clearance to market VIPER® and EXPEDIUM® Fenestrated Screw systems for use with cement to restore spinal column integrity in the treatment of advanced stage tumors.
Gramercy Extremity Orthopedics received FDA 510(k) clearance to market the GEO™ Bone Screw, indicated for fractures, osteotomies, arthrodesis, osteochondritis and tendon reattachment.
Vertebral Technologies was granted a U.S. patent addressing modular, in vivo assembly technology and its motion preservation InterCushion® pipeline product.
Implanet received global regulatory clearance for the Jazz Frame®, a system of connectors for use with JAZZ Band® technology in the treatment of spinal deformity. Launch is scheduled for 1Q17.
DePuy Synthes entered into an exclusive agreement with Pacira Pharmaceuticals for U.S. co-promotion of EXPAREL® local analgesic across its joint reconstruction, spine, sports medicine and trauma businesses.
OrthAlign received FDA 510(k) clearance to market the Direct Anterior Approach HipAlign® system, a handheld computer that provides cup placement accuracy data and measurement changes in leg length and joint offset.